Lobbying

Emed's latest lobbying report covers Q1 2025, at $40.5K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Emed

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Emed lobbying by quarter
Emed lobbying by quarter
QuarterAmountReports
Q4 2022$130K2
Q1 2023$02
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$37.5K1
Q4 2024$37.5K1
Q1 2025$40.5K1
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$205.5K · 5 reports
  • Medicare and Medicaid$40K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports

Firms it paid

Firm
The Vogel Group$115.5K3 quarters
Akin Gump Strauss Hauer & Feld$80K2 quarters
Clyburn Consulting$50K2 quarters

Former officials lobbying for it

Former position
ALEXANDER NICHOLAS VOGEL srFormer Chief Counsel, Senate Majority Leader Bill FristQ1 2025
WILLIAM CLYBURN jrVice Chairman & Commissioner, U.S. Surface Transportation Board; Senior Counsel to former U.S. Senator Zell MillerQ4 2022

Lobbying reports

Filed by
25/04/20for Q1 2025The Vogel Group$40.5K
25/01/20for Q4 2024The Vogel Group$37.5K
24/10/18for Q3 2024The Vogel Group$37.5K
24/08/20for Q3 2024The Vogel GroupUnder $5,000
23/04/20for Q1 2023Akin Gump Strauss Hauer & FeldUnder $5,000
23/04/18for Q1 2023Clyburn ConsultingUnder $5,000
23/01/20for Q4 2022Clyburn Consulting$50K
23/01/20for Q4 2022Akin Gump Strauss Hauer & Feld$80K